Emerging therapeutic targets for epilepsy: preclinical insights
Author:
Affiliation:
1. Department of Physiopathology, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland
2. Department of Pathophysiology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland
Funder
This paper is not funded
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14728222.2022.2039120
Reference110 articles.
1. Epilepsy: new advances
2. Pharmacoresistance – Epidemiology, mechanisms, and impact on epilepsy treatment
3. Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical Mechanisms
4. Refractory epilepsy: mechanisms and solutions
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revolutionizing Neurological Disorder Treatment: Integrating Innovations in Pharmaceutical Interventions and Advanced Therapeutic Technologies;Current Pharmaceutical Design;2024-05
2. The Love Hormone and Seizure Control: A Review of Oxytocin’s Impact on Epilepsy Management;Oxytocin and Social Function;2024-01-24
3. The Possible Role of Brain-derived Neurotrophic Factor in Epilepsy;Neurochemical Research;2023-11-25
4. Systemic inflammation as a biomarker of seizure propensity and a target for treatment to reduce seizure propensity;Epilepsia Open;2023-01-23
5. Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery;Current Drug Metabolism;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3